Lipid-Mediated Insertion of Toll-Like Receptor (TLR) Ligands for Facile Immune Cell Engineering

@article{Zhang2020LipidMediatedIO,
  title={Lipid-Mediated Insertion of Toll-Like Receptor (TLR) Ligands for Facile Immune Cell Engineering},
  author={M. H. Zhang and Emily Slaby and Georgina Stephanie and Chunsong Yu and D. Watts and H. Liu and Gregory L Szeto},
  journal={Frontiers in Immunology},
  year={2020},
  volume={11}
}
  • M. H. Zhang, Emily Slaby, +4 authors Gregory L Szeto
  • Published 2020
  • Chemistry, Medicine
  • Frontiers in Immunology
  • Cell-based immunotherapies have tremendous potential to treat many diseases, such as activating immunity in cancer or suppressing it in autoimmune diseases. Most cell-based cancer immunotherapies in the clinic provide adjuvant signals through genetic engineering to enhance T cell functions. However, genetically encoded signals have minimal control over dosing and persist for the life of a cell lineage. These properties make it difficult to balance increasing therapeutic efficacy with reducing… CONTINUE READING

    References

    SHOWING 1-10 OF 70 REFERENCES
    Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    • 20
    Targeting CpG Oligonucleotides to the Lymph Node by Nanoparticles Elicits Efficient Antitumoral Immunity1
    • 129
    • PDF
    High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.
    • 64
    • PDF
    Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized Immunotherapy**
    • 78
    TLR-9 signaling and TCR stimulation co-regulate CD8(+) T cell-associated PD-1 expression.
    • 24
    Toll-like receptor 9 antagonizes antibody affinity maturation
    • 27
    • PDF
    Cationic polymers for non‐viral gene delivery to human T cells
    • 49
    Programming Cell-Cell Interactions through Non-genetic Membrane Engineering.
    • 12